Sp655

PANEL DISCUSSION

Date
May 19, 2024
Explore related products in the following collection:

Presenters

Speaker Image for Glenn Furuta
Children
Speaker Image for Evan Dellon
University of North Carolina School of Medicine

Tracks

Related Products

Thumbnail for FLUTICASONE PROPIONATE ORAL DISINTEGRATING TABLET, APT-1011, LEADS TO A GREATER COMPLETE SYMPTOMATIC RESPONSE RATE COMPARED TO PLACEBO IN SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS (EOE)
FLUTICASONE PROPIONATE ORAL DISINTEGRATING TABLET, APT-1011, LEADS TO A GREATER COMPLETE SYMPTOMATIC RESPONSE RATE COMPARED TO PLACEBO IN SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS (EOE)
The goals of treatment of eosinophilic esophagitis (EoE) are to improve clinical symptoms and histologic features, as well as prevent progression to fibrostenotic complications. Few data currently exist that evaluate the effectiveness of therapies as measured by complete resolution of symptoms…
Thumbnail for FLUTICASONE PROPRIONATE ORAL DISINTEGRATING TABLET, APT-1011, IMPROVES FIBROSTENOTIC FEATURES OF STRICTURES AND GRADE 2/3 RINGS IN SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS (EOE)
FLUTICASONE PROPRIONATE ORAL DISINTEGRATING TABLET, APT-1011, IMPROVES FIBROSTENOTIC FEATURES OF STRICTURES AND GRADE 2/3 RINGS IN SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS (EOE)
Esophageal eosinophilic inflammation and remodeling lead to fibrostenosis in many patients with eosinophilic esophagitis (EoE)…
Thumbnail for HISTOLOGIC RESPONSE OR ENDOSCOPIC NORMALIZATION AFTER INTITIAL TREATMENT FOR EOSINOPHILIC ESOPHAGITIS IN CHILDREN LEADS TO LESS FIBROSTENOSIS OVER LONG-TERM FOLLOW-UP
HISTOLOGIC RESPONSE OR ENDOSCOPIC NORMALIZATION AFTER INTITIAL TREATMENT FOR EOSINOPHILIC ESOPHAGITIS IN CHILDREN LEADS TO LESS FIBROSTENOSIS OVER LONG-TERM FOLLOW-UP
BACKGROUND: Untreated eosinophilic esophagitis (EoE) can result in development of fibrostenosis over time, but there are few data on whether successful treatment in childhood decreases this risk as children with EoE transition to adulthood…